Synaptic silencing and plasma membrane dyshomeostasis induced by amyloid-β peptide are prevented by aristotelia chilensis enriched extract

Journal of Alzheimer's Disease

Volumn 31, Issue 4, 2012, Pages 879-889

  Fuentealba, Jorge ^a   Dibarrart, Andrea ^a   Saez Orellana, Francisco ^a   Fuentes Fuentes, María Cecilia ^a   Oyanedel, Carlos N ^a   Guzmán, José ^a   Perez, Claudia ^a   Becerra, José ^a   Aguayo, Luis G ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Alzheimer's disease; amyloid peptide; antioxidant; hippocampal neurons; maqui; nutraceuticals; polyphenols

Indexed keywords

AMYLOID BETA PROTEIN; ARISTOTELIA CHILENSIS ENRICHED EXTRACT; CALCIUM ION; NEUROPROTECTIVE AGENT; OLIGOMER; PLANT EXTRACT; POLYPHENOL; THIOFLAVINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARISTOTELIA CHILENSIS; ARTICLE; BERRY; BETA SHEET; BRAIN NERVE CELL; CALCIUM SIGNALING; CELL ACTIVITY; CELL MEMBRANE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; DRUG PURIFICATION; EXOCYTOSIS; FEMALE; HIPPOCAMPUS; NERVE CELL NETWORK; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; RAT; SYNAPTIC MEMBRANE;

EID: 84866341158     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120229     Document Type: Article

References (56)

1. Morris JC, Storandt M, McKeel DW Jr, Rubin EH, Price JL, Grant EA, Berg L (1996) Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology 46, 707-719.
2. Price BH, Gurvit H, Weintraub S, Geula C, Leimkuhler E, Mesulam M (1993) Neuropsychological patterns and language deficits in 20 consecutive cases of autopsy-confirmed Alzheimer's disease. Arch Neurol 50, 931-937.
3. Gauci AJ, Caruana M, Giese A, Scerri C, Vassallo N (2011) Identification of polyphenolic compounds and black tea extract as potent inhibitors of lipid membrane destabilization by abeta42 aggregates. J Alzheimers Dis 27, 767-779.
4. Selkoe DJ (1996) Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 271, 18295-18298.
5. Suh YH, Checler F (2002) Amyloid precursor protein, presenilins, and alpha-synuclein: Molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol Rev 54, 469-525.
6. Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H, Takuma H, Kuwano R, Imagawa M, Ataka S, Wada Y, Yoshioka E, Nishizaki T, Watanabe Y, Mori H (2008) A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia. Ann Neurol 63, 377-387.
7. Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L Jr, Eckman C, Golde TE, Younkin SG (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264, 1336-1340.
8. Haass C, De StrooperB(1999) The presenilins in Alzheimer's disease-proteolysis holds the key. Science 286, 916-919.
9. Selkoe DJ (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8, 447-453.
10. Soto C, Branes MC, Alvarez J, Inestrosa NC (1994) Structural determinants of the Alzheimer's amyloid beta-peptide. J Neurochem 63, 1191-1198.
11. Jarrett JT, Berger EP, Lansbury PT Jr (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697.
12. Einstein G, Buranosky R, Crain BJ (1994) Dendritic pathology of granule cells in Alzheimer's disease is unrelated to neuritic plaques. J Neurosci 14, 5077-5088.
13. Gearing M, Wilson RW, Unger ER, Shelton ER, Chan HW, Masters CL, Beyreuther K, Mirra SS (1993) Amyloid precursor protein (APP) in the striatum in Alzheimer's disease: An immunohistochemical study. J Neuropathol Exp Neurol 52, 22-30.
14. Cochran E, Bacci B, Chen Y, Patton A, Gambetti P, Autilio- Gambetti L (1991) Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease. Am J Pathol 139, 485-489.
15. Cuevas ME, Haensgen H, Sepulveda FJ, Zegers G, Roa J, Opazo C, Aguayo LG (2011) Soluble Abeta(1-40) peptide increases excitatory neurotransmission and induces epileptiform activity in hippocampal neurons. J Alzheimers Dis 23, 673-687.
16. KleinWL(2002) Abeta toxicity in Alzheimer's disease: Globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem Int 41, 345-352.
17. Koistinaho M, Ort M, Cimadevilla JM, Vondrous R, Cordell B, Koistinaho J, Bures J, Higgins LS (2001) Specific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta - amyloid deposits but do not form plaques. Proc Natl Acad Sci U S A 98, 14675-14680.
18. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357.
19. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
20. Zhu YJ, Lin H, Lal R (2000) Fresh and nonfibrillar amyloid beta protein(1-40) induces rapid cellular degeneration in aged human fibroblasts: Evidence for AbetaP-channel-mediated cellular toxicity. FASEB J 14, 1244-1254.
21. Resende R, Pereira C, Agostinho P, Vieira AP, Malva JO, Oliveira CR (2007) Susceptibility of hippocampal neurons to Abeta peptide toxicity is associated with perturbation of Ca2+ homeostasis. Brain Res 1143, 11-21.
22. Walsh DM, Townsend M, Podlisny MB, Shankar GM, Fadeeva JV, El Agnaf O, Hartley DM, Selkoe DJ (2005) Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation. J Neurosci 25, 2455- 2462.
23. Parodi J, Sepulveda FJ, Roa J, Opazo C, Inestrosa NC, Aguayo LG(2010) Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J Biol Chem 285, 2506- 2514.
24. Sepulveda FJ, Opazo C, Aguayo LG (2009) Alzheimer betaamyloid blocks epileptiform activity in hippocampal neurons. Mol Cell Neurosci 41, 420-428.
25. Arispe N, Rojas E, Pollard HB (1993) Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: Blockade by tromethamine and aluminum. Proc Natl Acad Sci U S A 90, 567-571.
26. Fuentealba J, Dibarrart AJ, Fuentes-Fuentes MC, Saez- Orellana F, Quinones K, Guzman L, Perez C, Becerra J, Aguayo LG (2011) Synaptic failure and adenosine triphosphate imbalance induced by amyloid-beta aggregates are prevented by blueberry-enriched polyphenols extract. J Neurosci Res 89, 1499-1508.
27. Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K (2010) Biomarkers for Alzheimer's disease: Academic, industry and regulatory perspectives. Nat Rev Drug Discov 9, 560-574.
28. Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, 230S-242S.
29. Joseph JA, Shukitt-Hale B, Denisova NA, Bielinski D, Martin A, McEwen JJ, Bickford PC (1999) Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 19, 8114-8121.
30. Hull M, Berger M, HenekaM(2006) Disease-modifying therapies in Alzheimer's disease: How far have we come? Drugs 66, 2075-2093.
31. Aguirre MC, Delporte C, Backhouse N, Erazo S, Letelier ME, Cassels BK, Silva X, Alegria S, Negrete R (2006) Topical anti-inflammatory activity of 2alpha-hydroxy pentacyclic triterpene acids from the leaves of Ugni molinae. Bioorg Med Chem 14, 5673-5677.
32. Delporte C, Backhouse N, Inostroza V, Aguirre MC, Peredo N, Silva X, Negrete R, Miranda HF (2007) Analgesic activity of Ugni molinae (murtilla) in mice models of acute pain. J Ethnopharmacol 112, 162-165.
33. Mandel S, Amit T, Reznichenko L, Weinreb O, Youdim MB (2006) Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. Mol Nutr Food Res 50, 229-234.
34. Rubilar M, Pinelo M, Ihl M, Scheuermann E, Sineiro J, Nunez MJ (2006) Murta leaves (Ugni molinae Turcz) as a source of antioxidant polyphenols. J Agric Food Chem 54, 59-64.
35. Wang J, Ho L, Zhao Z, Seror I, Humala N, Dickstein DL, Thiyagarajan M, Percival SS, Talcott ST, PasinettiGM(2006) Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. FASEB J 20, 2313-2320.
36. Wu Y, Wu Z, Butko P, Christen Y, Lambert MP, Klein WL, Link CD, Luo Y (2006) Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci 26, 13102-13113.
37. Harikumar KB, Aggarwal BB (2008) Resveratrol: A multitargeted agent for age-associated chronic diseases. Cell Cycle 7, 1020-1035.
38. Porat Y, Abramowitz A, Gazit E (2006) Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 67, 27-37.
39. Riviere C, Richard T,Vitrac X, Merillon JM,Valls J, Monti JP (2008) New polyphenols active on beta-amyloid aggregation. Bioorg Med Chem Lett 18, 828-831.
40. Yang F, LimGP,BegumAN, Ubeda OJ, SimmonsMR,Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, ColeGM(2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280, 5892-5901.
41. Bastianetto S, Brouillette J, Quirion R (2007) Neuroprotective effects of natural products: Interaction with intracellular kinases, amyloid peptides and a possible role for transthyretin. Neurochem Res 32, 1720-1725.
42. Joseph JA, Carey A, Brewer GJ, Lau FC, Fisher DR (2007) Dopamine and Abeta-induced stress signaling and decrements in Ca2+ buffering in primary neonatal hippocampal cells are antagonized by blueberry extract. J Alzheimers Dis 11, 433-446.
43. Rubilar M, Jara C, Poo Y, Acevedo F, Gutierrez C, Sineiro J, Shene C (2011) Extracts of Maqui (Aristotelia chilensis) and Murta (Ugni molinae Turcz): Sources of antioxidant compounds and alpha-glucosidase/alpha-amylase inhibitors. J Agric Food Chem 59, 1630-1637.
44. Ruiz A, Hermosin-Gutierrez I, Mardones C, Vergara C, Herlitz E, Vega M, Dorau C, Winterhalter P, von Baer D (2010) Polyphenols and antioxidant activity of calafate (Berberis microphylla) fruits and other native berries from Southern Chile. J Agric Food Chem 58, 6081-6089.
45. Ferreiro E, Eufrasio A, Pereira C, Oliveira CR, Rego AC (2007) Bcl-2 overexpression protects against amyloid-beta and prion toxicity in GT1-7 neural cells. J Alzheimers Dis 12, 223-228.
46. Latini A, da Silva CG, Ferreira GC, Schuck PF, Scussiato K, Sarkis JJ, Dutra Filho CS, Wyse AT, Wannmacher CM, Wajner M (2005) Mitochondrial energy metabolism is markedly impaired by D-2-hydroxyglutaric acid in rat tissues. Mol Genet Metab 86, 188-199.
47. Xia YP, Dai RL, Li YN, Mao L, Xue YM, He QW, Huang M, Huang Y, Mei YW, Hu B (2012) The protective effect of sonic hedgehog is mediated by the propidium iodide 3- kinase/AKT/BCL-2 pathway in cultured rat astrocytes under oxidative stress. Neuroscience 209, 1-11.
48. Carrasco MA, Castro PA, Sepulveda FJ, Cuevas M, Tapia JC, Izaurieta P, van Zundert B, Aguayo LG (2007) Antihomeostatic synaptic plasticity of glycine receptor function after chronic strychnine in developing cultured mouse spinal neurons. J Neurochem 100, 1143-1154.
49. Sepulveda FJ, Parodi J, Peoples RW, Opazo C, Aguayo LG (2010) Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property. PLoS One 5, e11820.
50. Joseph JA, Denisova NA, Arendash G, Gordon M, Diamond D, Shukitt-Hale B, Morgan D (2003) Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 6, 153-162.
51. Joseph JA, Shukitt-Hale B, Willis LM (2009) Grape juice, berries, and walnuts affect brain aging and behavior. J Nutr 139, 1813S-1817S.
52. Lau FC, Shukitt-Hale B, Joseph JA (2005) The beneficial effects of fruit polyphenols on brain aging. Neurobiol Aging 26(Suppl 1), 128-132.
53. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L (2004) Polyphenols: Food sources and bioavailability. Am J Clin Nutr 79, 727-747.
54. Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H, Jeanniton D, Ehrhart J, Townsend K, Zeng J, Morgan D, Hardy J, Town T, Tan J (2005) Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 25, 8807-8814.
55. Savaskan E, Olivieri G, Meier F, Seifritz E, Wirz-Justice A, Muller-Spahn F (2003) Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity. Gerontology 49, 380-383.
56. Scalbert A, Johnson IT, Saltmarsh M (2005) Polyphenols: Antioxidants and beyond. Am J Clin Nutr 81, 215S-217S.